Cargando…

Changes in Body Composition and FTO Whole Blood DNA Methylation Among Japanese Women: A Randomized Clinical Trial of Weight-Loss Program

OBJECTIVE: DNA methylation is an epigenetic mechanism that regulates gene expression. The obesity-related (FTO) gene is the first gene found to be associated with fat mass and obesity. However, no studies have examined the relationship between weight-loss intervention effect and FTO methylation in o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Haruhiko, Onishi, Katsuko, Kurose, Satoshi, Tsutsumi, Hiromi, Miyauchi, Takumi, Takao, Nana, Yoshiuchi, Sawako, Fujii, Aya, Kimura, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320880/
https://www.ncbi.nlm.nih.gov/pubmed/32606874
http://dx.doi.org/10.2147/DMSO.S248769
_version_ 1783551336667676672
author Nishida, Haruhiko
Onishi, Katsuko
Kurose, Satoshi
Tsutsumi, Hiromi
Miyauchi, Takumi
Takao, Nana
Yoshiuchi, Sawako
Fujii, Aya
Kimura, Yutaka
author_facet Nishida, Haruhiko
Onishi, Katsuko
Kurose, Satoshi
Tsutsumi, Hiromi
Miyauchi, Takumi
Takao, Nana
Yoshiuchi, Sawako
Fujii, Aya
Kimura, Yutaka
author_sort Nishida, Haruhiko
collection PubMed
description OBJECTIVE: DNA methylation is an epigenetic mechanism that regulates gene expression. The obesity-related (FTO) gene is the first gene found to be associated with fat mass and obesity. However, no studies have examined the relationship between weight-loss intervention effect and FTO methylation in obese individuals with whole blood DNA. The purpose of this study was to quantify FTO whole blood DNA methylation and investigate the relationship between body composition, exercise capacity, and blood parameters with a 6-month weight-loss program intervention. PARTICIPANTS AND METHODS: Eighteen female participants (mean age, 50.6 ±12.1 years, body mass index (BMI), 33.5 ± 6.2 kg/m(2)) who completed a 6-month weight-loss program at the obesity outpatient department at the Health Science Center of Kansai Medical University Hospital from March 2017 to October 2018 were included in the analysis. Participants were randomized into a normal treatment group (NTG) and a group with additional resistance training (RTG). Body composition, exercise tolerance and metabolic index were measured in each participant. DNA methylation status in whole blood samples was determined using pyrosequencing. All measurements were taken during the first visit and at the 6-month post-intervention visit. RESULTS: The methylation rate was significantly decreased in the NTG in CpG1 (p=0.011) and total value of CpG (p=0.011), whereas in the treatment group containing resistance training (RTG), CpG3 (p=0.038) was increased significantly. Furthermore, the independent factors that determine %CpG3 of RTG were visceral fat area change rate (%VFA) (β = −0.568, P = 0.007, R2 = 0.527) and resistance training (β = 0.517, P = 0.012, R2 = 0.527), which have been extracted. CONCLUSION: A 6-month weight-loss program, including resistance training, may be associated with decreased visceral fat area changes and increased RTG CpG3 methylation changes. However, further replication studies with larger sample sizes are warranted to verify the findings of this study.
format Online
Article
Text
id pubmed-7320880
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73208802020-06-29 Changes in Body Composition and FTO Whole Blood DNA Methylation Among Japanese Women: A Randomized Clinical Trial of Weight-Loss Program Nishida, Haruhiko Onishi, Katsuko Kurose, Satoshi Tsutsumi, Hiromi Miyauchi, Takumi Takao, Nana Yoshiuchi, Sawako Fujii, Aya Kimura, Yutaka Diabetes Metab Syndr Obes Original Research OBJECTIVE: DNA methylation is an epigenetic mechanism that regulates gene expression. The obesity-related (FTO) gene is the first gene found to be associated with fat mass and obesity. However, no studies have examined the relationship between weight-loss intervention effect and FTO methylation in obese individuals with whole blood DNA. The purpose of this study was to quantify FTO whole blood DNA methylation and investigate the relationship between body composition, exercise capacity, and blood parameters with a 6-month weight-loss program intervention. PARTICIPANTS AND METHODS: Eighteen female participants (mean age, 50.6 ±12.1 years, body mass index (BMI), 33.5 ± 6.2 kg/m(2)) who completed a 6-month weight-loss program at the obesity outpatient department at the Health Science Center of Kansai Medical University Hospital from March 2017 to October 2018 were included in the analysis. Participants were randomized into a normal treatment group (NTG) and a group with additional resistance training (RTG). Body composition, exercise tolerance and metabolic index were measured in each participant. DNA methylation status in whole blood samples was determined using pyrosequencing. All measurements were taken during the first visit and at the 6-month post-intervention visit. RESULTS: The methylation rate was significantly decreased in the NTG in CpG1 (p=0.011) and total value of CpG (p=0.011), whereas in the treatment group containing resistance training (RTG), CpG3 (p=0.038) was increased significantly. Furthermore, the independent factors that determine %CpG3 of RTG were visceral fat area change rate (%VFA) (β = −0.568, P = 0.007, R2 = 0.527) and resistance training (β = 0.517, P = 0.012, R2 = 0.527), which have been extracted. CONCLUSION: A 6-month weight-loss program, including resistance training, may be associated with decreased visceral fat area changes and increased RTG CpG3 methylation changes. However, further replication studies with larger sample sizes are warranted to verify the findings of this study. Dove 2020-06-23 /pmc/articles/PMC7320880/ /pubmed/32606874 http://dx.doi.org/10.2147/DMSO.S248769 Text en © 2020 Nishida et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Nishida, Haruhiko
Onishi, Katsuko
Kurose, Satoshi
Tsutsumi, Hiromi
Miyauchi, Takumi
Takao, Nana
Yoshiuchi, Sawako
Fujii, Aya
Kimura, Yutaka
Changes in Body Composition and FTO Whole Blood DNA Methylation Among Japanese Women: A Randomized Clinical Trial of Weight-Loss Program
title Changes in Body Composition and FTO Whole Blood DNA Methylation Among Japanese Women: A Randomized Clinical Trial of Weight-Loss Program
title_full Changes in Body Composition and FTO Whole Blood DNA Methylation Among Japanese Women: A Randomized Clinical Trial of Weight-Loss Program
title_fullStr Changes in Body Composition and FTO Whole Blood DNA Methylation Among Japanese Women: A Randomized Clinical Trial of Weight-Loss Program
title_full_unstemmed Changes in Body Composition and FTO Whole Blood DNA Methylation Among Japanese Women: A Randomized Clinical Trial of Weight-Loss Program
title_short Changes in Body Composition and FTO Whole Blood DNA Methylation Among Japanese Women: A Randomized Clinical Trial of Weight-Loss Program
title_sort changes in body composition and fto whole blood dna methylation among japanese women: a randomized clinical trial of weight-loss program
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320880/
https://www.ncbi.nlm.nih.gov/pubmed/32606874
http://dx.doi.org/10.2147/DMSO.S248769
work_keys_str_mv AT nishidaharuhiko changesinbodycompositionandftowholeblooddnamethylationamongjapanesewomenarandomizedclinicaltrialofweightlossprogram
AT onishikatsuko changesinbodycompositionandftowholeblooddnamethylationamongjapanesewomenarandomizedclinicaltrialofweightlossprogram
AT kurosesatoshi changesinbodycompositionandftowholeblooddnamethylationamongjapanesewomenarandomizedclinicaltrialofweightlossprogram
AT tsutsumihiromi changesinbodycompositionandftowholeblooddnamethylationamongjapanesewomenarandomizedclinicaltrialofweightlossprogram
AT miyauchitakumi changesinbodycompositionandftowholeblooddnamethylationamongjapanesewomenarandomizedclinicaltrialofweightlossprogram
AT takaonana changesinbodycompositionandftowholeblooddnamethylationamongjapanesewomenarandomizedclinicaltrialofweightlossprogram
AT yoshiuchisawako changesinbodycompositionandftowholeblooddnamethylationamongjapanesewomenarandomizedclinicaltrialofweightlossprogram
AT fujiiaya changesinbodycompositionandftowholeblooddnamethylationamongjapanesewomenarandomizedclinicaltrialofweightlossprogram
AT kimurayutaka changesinbodycompositionandftowholeblooddnamethylationamongjapanesewomenarandomizedclinicaltrialofweightlossprogram